newsfilter
← Latest News
Business Wire·

Epizyme Announces Proposed Public Offering of Common Stock

Epizyme, Inc. (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that it intends to offer and sell shares of its common stock in an underwritten public offe